In vitro efficacy of artemisinin-based treatments against SARS-CoV-2
Abstract Effective and affordable treatments for patients suffering from coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are needed. We report in vitro efficacy of Artemisia annua extracts as well as artemisinin, artesunate, and artemether...
Guardado en:
Autores principales: | Yuyong Zhou, Kerry Gilmore, Santseharay Ramirez, Eva Settels, Karen A. Gammeltoft, Long V. Pham, Ulrik Fahnøe, Shan Feng, Anna Offersgaard, Jakob Trimpert, Jens Bukh, Klaus Osterrieder, Judith M. Gottwein, Peter H. Seeberger |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cb60e70748c8410cbc59a6f8b48eb14d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Productive homologous and non-homologous recombination of hepatitis C virus in cell culture.
por: Troels K H Scheel, et al.
Publicado: (2013) -
Artemisinin analogues as potent inhibitors of in vitro hepatitis C virus replication.
por: Susan Obeid, et al.
Publicado: (2013) -
Nanoliposomal artemisinin for the treatment of murine visceral leishmaniasis
por: Want MY, et al.
Publicado: (2017) -
Aging affects artemisinin synthesis in Artemisia annua
por: Jiao Li, et al.
Publicado: (2021) -
Absence of Plasmodium falciparum artemisinin resistance gene mutations eleven years after the adoption of artemisinin-based combination therapy in Nigeria
por: Moses Ikegbunam, et al.
Publicado: (2021)